Velpatasvir | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Velpatasvir
US Exclusivities

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Velpatasvir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 3 EU WC, 4 NDC API, 8 Listed Suppliers, $ API Reference Price

9 API Suppliers
3 EU WC
4 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

11 FDF Dossiers, 5 FDA Orange Book, 1 Europe, 2 Canada, 3 Listed Dossiers

11 FDF Dossiers
5 FDA Orange Book
1 Europe
2 Canada
3 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 6 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 10 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 Vasa Pharmachem

1 SPI Pharma
3 DKSH
3 Faran Shimi Pharmaceutical
2 Boai NKY Pharmaceuticals Ltd
4 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
1 Actylis
1 Aeon Procare
1 Alcedo Pharmachem
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
3 BASF
5 Corel Pharma Chem
5 DFE Pharma
6 Gangwal Chemicals
1 Huzhou Sunflower Pharmaceutical
3 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
20 Kerry
10 Microlex e.U
2 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
10 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
11 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 21 Coating Systems & Additives, 16 Direct Compression, 14 Disintegrants & Superdisintegrants, 12 Lubricants & Glidants, 12 Granulation, 10 Controlled & Modified Release, 9 Thickeners and Stabilizers, 8 Film Formers & Plasticizers, 7 Co-Processed Excipients, 4 Taste Masking, 3 Parenteral, 3 Coloring Agents, 2 Solubilizers, 2 Topical, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Emulsifying Agents

44 Fillers, Diluents & Binders
21 Coating Systems & Additives
16 Direct Compression
14 Disintegrants & Superdisintegrants
12 Lubricants & Glidants
12 Granulation
10 Controlled & Modified Release
9 Thickeners and Stabilizers
8 Film Formers & Plasticizers
7 Co-Processed Excipients
4 Taste Masking
3 Parenteral
3 Coloring Agents
2 Solubilizers
2 Topical
2 Rheology Modifiers
2 Chewable & Orodispersible Aids
1 API Stability Enhancers
1 Emulsifying Agents

DIGITAL CONTENT

7 News #PharmaBuzz

7 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices, 4 Annual Reports

1 Regulatory FDF Prices
4 Annual Reports

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

163 US Patents, 16 US Exclusivities

163 US Patents
16 US Exclusivities

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ API Ref.Price (USD/KG) : 3,971 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

16 All

01 16GILEAD SCIENCES INC

filter Product Reset all filters

16 All

01 16SOFOSBUVIR; VELPATASVIR

filter Exclusivity Expiration Date Reset all filters

16 All

01 42025-04-27

02 22027-03-19

03 22027-09-19

04 42028-06-10

05 42028-12-10

filter Exclusivity Code Reset all filters

16 All

01 4M-277

02 2ODE-293

03 4ODE-376

04 6PED

Product Main Page

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

214187

Product Number

2

Exclusivity Details

01

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 214187

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

214187

Product Number

2

Exclusivity Details

02

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 214187

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

208341

Product Number

2

Exclusivity Details

03

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

208341

Product Number

2

Exclusivity Details

04

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-293

Exclusivity Expiration Date

2027-03-19

Application Number

208341

Product Number

2

Exclusivity Details

05

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-293

Exclusivity Expiration Date : 2027-03-19

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

208341

Product Number

1

Exclusivity Details

06

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

208341

Product Number

1

Exclusivity Details

07

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

214187

Product Number

1

Exclusivity Details

08

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 214187

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-293

Exclusivity Expiration Date

2027-03-19

Application Number

208341

Product Number

1

Exclusivity Details

09

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-293

Exclusivity Expiration Date : 2027-03-19

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

214187

Product Number

1

Exclusivity Details

10

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Immuno-Oncology 360

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 214187

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!